Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model

Laboratory Investigation

Volumn 92, Issue 1, 2012, Pages 151-162

  Wang, Shu Chi ^a   Hong, Ji Hong ^b   Hsueh, Chuen ^b   Chiang, Chi Shiun ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

glioma; invasion; SDF 1; tumor associated macrophages

Indexed keywords

STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; CANCER INVASION; CELL HYPOXIA; GLIOMA; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ASTROCYTOMA; BRAIN NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; MACROPHAGES; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; RECEPTORS, CXCR4; TROPISM; TUMOR MICROENVIRONMENT;

EID: 84855251694     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.128     Document Type: Article

References (61)

1. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-996. (Pubitemid 40349501)
2. Gladson CL, Prayson RA, Liu WM. The pathobiology of glioma tumors. Annu Rev Pathol 2010;5:33-50.
3. Brown JM. The hypoxic cell: a target for selective cancer therapy- eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 1999; 59:5863-5870. (Pubitemid 30004940)
4. Pilkington GJ, Darling JL, Lantos PL, et al. Cell lines (VMDk) derived from a spontaneous murine astrocytoma. Morphological and immunocytochemical characterization. J Neurol Sci 1983;62:115-139. (Pubitemid 14176243)
5. Yamasaki T, Handa H, Yamashita J, et al. Characteristic immunological responses to an experimental mouse brain tumor. Cancer Res 1983; 43:4610-4617. (Pubitemid 13014190)
6. Morris VL, Tieszer C, Mackinnon J, et al. Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease. Virology 1989;169:127-136. (Pubitemid 19080155)
7. Weiner NE, Pyles RB, Chalk CL, et al. A syngeneic mouse glioma model for study of glioblastoma therapy. J Neuropathol Exp Neurol 1999;58:54-60. (Pubitemid 29053026)
8. Szatmari T, Lumniczky K, Desaknai S, et al. Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci 2006;97:546-553. (Pubitemid 43811598)
9. Nishie A, Ono M, Shono T, et al. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 1999;5:1107-1113. (Pubitemid 29233226)
10. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66:605-612. (Pubitemid 43165918)
11. Tabatabai G, Frank B, Mohle R, et al. Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGFbeta- dependent HIF-1alpha-mediated induction of CXCL12. Brain 2006;129:2426-2435. (Pubitemid 44522127)
12. Esencay M, Newcomb EW, Zagzag D. HGF upregulates CXCR4 expression in gliomas via NF-kappaB: implications for glioma cell migration. J Neurooncol 2010;99:33-40.
13. Balkwill F. Chemokine biology in cancer. Semin Immunol 2003;15: 49-55. (Pubitemid 36092178)
14. Dewan MZ, Ahmed S, Iwasaki Y, et al. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed Pharmacother 2006;60:273-276. (Pubitemid 44223937)
15. Luker KE, Luker GD. Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 2006;238:30-41. (Pubitemid 44183757)
16. Liang Z, Wu H, Reddy S, et al. Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA. Biochem Biophys Res Commun 2007;363:542-546. (Pubitemid 47513664)
17. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121:335-348. (Pubitemid 40692295)
18. Zheng H, Fu G, Dai T, et al. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/ eNOS signal transduction pathway. J Cardiovasc Pharmacol 2007;50: 274-280. (Pubitemid 47428975)
19. Chiang CS, McBride WH. Radiation enhances tumor necrosis factor alpha production by murine brain cells. Brain Res 1991;566: 265-269.
20. Ariga H, Sugano S. Initiation of simian virus 40 DNA replication in vitro. J Virol 1983;48:481-491. (Pubitemid 13019278)
21. Newcomb EW, Lukyanov Y, Kawashima N, et al. Radiotherapy enhances antitumor effect of anti-CD137 therapy in a mouse Glioma model. Radiat Res 2010;173:426-432.
22. Mendez O, Zavadil J, Esencay M, et al. Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Mol Cancer 2010;9:133.
23. Foster BA, Gingrich JR, Kwon ED, et al. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res 1997;57: 3325-3330. (Pubitemid 27355467)
24. Ohgaki H, Kleihues P. Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci 2009;100:2235-2241.
25. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol 2007;170:1445-1453. (Pubitemid 47339290)
26. Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321:1807-1812.
27. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002;196:254-265. (Pubitemid 34189413)
28. Salmaggi A, Gelati M, Pollo B, et al. CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J Neurooncol 2004;67:305-317. (Pubitemid 39137361)
29. Aghi M, Cohen KS, Klein RJ, et al. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer Res 2006;66:9054-9064. (Pubitemid 44521124)
30. Komatani H, Sugita Y, Arakawa F, et al. Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas. Int J Oncol 2009;34: 665-672.
31. Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004;104:2224-2234. (Pubitemid 39331817)
32. Lewis JS, Lee JA, Underwood JC, et al. Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 1999;66: 889-900. (Pubitemid 30010512)
33. Zagzag D, Miller DC, Chiriboga L, et al. Green fluorescent protein immunohistochemistry as a novel experimental tool for the detection of glioma cell invasion in vivo. Brain Pathol 2003;13:34-37. (Pubitemid 36133790)
34. Zagzag D, Zhong H, Scalzitti JM, et al. Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 2000;88:2606-2618. (Pubitemid 30331970)
35. Zagzag D, Amirnovin R, Greco MA, et al. Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest 2000;80:837-849. (Pubitemid 30421801)
36. Newcomb EW, Zagzag D. The Murine GL261 glioma experimental model to assess novel brain tumor treatments. In: Van Meir EG (ed). Cancer Drug Discovery and Development. Humana Press: Atlanta, GA, 2009, pp 227-241.
37. Moskovits N, Kalinkovich A, Bar J, et al. p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Res 2006;66:10671-10676. (Pubitemid 44876961)
38. Addadi Y, Moskovits N, Granot D, et al. p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner. Cancer Res 2010;70:9650-9658.
39. Aiuti A, Webb IJ, Bleul C, et al. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997;185:111-120. (Pubitemid 27039446)
40. Pusic I, DiPersio JF. Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells. Curr Opin Hematol 2010;17:319-326.
41. Kioi M, Vogel H, Schultz G, et al. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 2010;120:694-705.
42. Rempel SA, Dudas S, Ge S, et al. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 2000;6:102-111. (Pubitemid 30064982)
43. Salvucci O, Yao L, Villalba S, et al. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002;99:2703-2711. (Pubitemid 34525355)
44. Salcedo R, Oppenheim JJ. Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation 2003;10:359-370. (Pubitemid 39004262)
45. Kenig S, Alonso MB, Mueller MM, et al. Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9. Cancer Lett 2010;289:53-61.
46. Rehman AO, Wang CY. CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex. Int J Oral Sci 2009;1:105-118.
47. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858-864. (Pubitemid 39070860)
48. Wang Y, Haider H, Ahmad N, et al. Evidence for ischemia induced hostderived bone marrow cell mobilization into cardiac allografts. J Mol Cell Cardiol 2006;41:478-487. (Pubitemid 44349132)
49. Jin DK, Shido K, Kopp HG, et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006;12:557-567.
50. Grunewald M, Avraham I, Dor Y, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006; 124:175-189. (Pubitemid 43069318)
51. Fang HY, Hughes R, Murdoch C, et al. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 2009;114:844-859.
52. Yin Q, Jin P, Liu X, et al. SDF-1alpha inhibits hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells through PI3K/Akt and ERK1/2 signaling pathways. Mol Biol Rep 2011;38:9-16.
53. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010;141:39-51.
54. Mantovani A, Ming WJ, Balotta C, et al. Origin and regulatin of tumorassociated macrophages: the role of tumor-derived chemotactic factor. Biochim Biophys Acta 1986;865:59-67. (Pubitemid 16050203)
55. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71-78. (Pubitemid 38082155)
56. Tsai CS, Chen FH, Wang CC, et al. Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth. Int J Radiat Oncol Biol Phys 2007;68:499-507.
57. Chiang CS, Chen FH, Hong JH, et al. Functional phenotype of macrophages depends on assay procedures. Int Immunol 2008;20: 215-222.
58. Stout RD, Jiang C, Matta B, et al. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005;175:342-349. (Pubitemid 40884337)
59. Watters JJ, Schartner JM, Badie B. Microglia function in brain tumors. J Neurosci Res 2005;81:447-455. (Pubitemid 41359299)
60. Lewis CE, Leek R, Harris A, et al. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 1995;57:747-751.
61. Murdoch C, Muthana M, Lewis CE. Hypoxia regulates macrophage functions in inflammation. J Immunol 2005;175:6257-6263. (Pubitemid 41598863)